Over 3 days 66 companies converged at the World Bispecific Summit to share new research, data and lessons learned in the quest to develop more clinically successful bispecific drugs.
It was clear from the talks and discussions that huge progress has been made in understanding what the challenges are in bispecific development, but that much is still needed to resolve them.
The field remains highly optimistic and the hope is that many more patients can benefit from these types of therapies now that Blincyto has proved the benefit that bispecifics can provide.
We very much hope you can join us next year! The dates for your diary for the World Bispecific Summit 2016 are 27th-29th September.
“Very well organized conference and very focused on topics that matter. Top speakers. The best conference in the field in my opinion.”
“This meeting provided a very good, detailed and critical overview of the field of bispecific biologics.”
“World Bispecific Antibody Summit provides excellent mix of science and networking”